adult primary hepatocellular carcinoma
Showing 1 - 25 of 28
Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer, Recurrent Adult Primary Liver Cancer Trial in
Active, not recruiting
- Adult Primary Hepatocellular Carcinoma
- +2 more
- sorafenib tosylate
- stereotactic body radiation therapy
-
Berkeley, California
- +50 more
Nov 17, 2022
Adult Primary Hepatocellular Carcinoma, Localized Resectable Adult Primary Liver Cancer, Localized Unresectable Adult Primary
Suspended
- Adult Primary Hepatocellular Carcinoma
- +3 more
- sorafenib tosylate
- +2 more
-
Birmingham, Alabama
- +20 more
Aug 29, 2022
Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer, Metastatic Extrahepatic Bile Duct Cancer Trial in
Active, not recruiting
- Adult Primary Hepatocellular Carcinoma
- +6 more
- PET scan
- +2 more
-
Philadelphia, PennsylvaniaFox Chase Cancer Center
Jul 21, 2022
Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer, Advanced Adult Hepatocellular Carcinoma Trial in
Completed
- Adult Primary Hepatocellular Carcinoma
- +4 more
- Chinese herbal formulation PHY906
- +3 more
-
Duarte, CaliforniaCity of Hope Medical Center
Jan 26, 2021
Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer, Localized Unresectable Adult Primary Liver Cancer
Recruiting
- Adult Primary Hepatocellular Carcinoma
- +3 more
- yttrium Y 90 glass microspheres
- laboratory biomarker analysis
-
Columbus, OhioArthur G. James Cancer Hospital and Solove Research Institute at
Sep 17, 2020
Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer, Localized Resectable Adult Primary Liver Cancer
Terminated
- Adult Primary Hepatocellular Carcinoma
- +5 more
- 3 Tesla Magnetic Resonance Imaging
- Magnevist® (Intravenous (IV) administration of MRI contrast agent)
-
Nashville, TennesseeVanderbilt-Ingram Cancer Center
Jul 10, 2018
Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer, Recurrent Adult Primary Liver Cancer Trial in Los
Terminated
- Adult Primary Hepatocellular Carcinoma
- +2 more
-
Los Angeles, CaliforniaUniversity of Southern California, Norris
Mar 20, 2018
Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer, Localized Unresectable Adult Primary Liver Cancer
Completed
- Adult Primary Hepatocellular Carcinoma
- +3 more
-
Madison, Wisconsin
- +1 more
Oct 3, 2017
Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer, Localized Unresectable Adult Primary Liver Cancer
Terminated
- Adult Primary Hepatocellular Carcinoma
- +3 more
- sunitinib malate
- capecitabine
-
Seattle, WashingtonFred Hutchinson Cancer Research Center/University of Washington
Apr 27, 2017
Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer, Localized Unresectable Adult Primary Liver Cancer
Terminated
- Adult Primary Hepatocellular Carcinoma
- +3 more
- cediranib maleate
- +4 more
-
Boston, MassachusettsMassachusetts General Hospital Cancer Center
Sep 13, 2016
Adult Primary Hepatocellular Carcinoma, Localized Unresectable Adult Primary Liver Cancer, Recurrent Adult Primary Liver Cancer
Completed
- Adult Primary Hepatocellular Carcinoma
- +2 more
- bevacizumab
-
Bronx, New YorkMontefiore Medical Center - Moses Campus
Jan 29, 2016
Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer, Localized Unresectable Adult Primary Liver Cancer
Completed
- Adult Primary Hepatocellular Carcinoma
- +2 more
- thalidomide
- +2 more
-
New York, New YorkNew York University Langone Medical Center
Apr 14, 2015
Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer, Localized Resectable Adult Primary Liver Cancer
Completed
- Adult Primary Hepatocellular Carcinoma
- +4 more
- sorafenib tosylate
- laboratory biomarker analysis
-
Seattle, WashingtonFred Hutchinson Cancer Research Center/University of Washington
Mar 25, 2015
Adult Primary Hepatocellular Carcinoma, Recurrent Adult Primary Liver Cancer, Stage I Adult Primary Liver Cancer Trial
Withdrawn
- Adult Primary Hepatocellular Carcinoma
- +4 more
- transarterial chemoembolization
- stereotactic radiosurgery
- (no location specified)
Dec 1, 2014
Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer, Localized Unresectable Adult Primary Liver Cancer
Completed
- Adult Primary Hepatocellular Carcinoma
- +3 more
-
Boston, MassachusettsEastern Cooperative Oncology Group
Oct 24, 2014
Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer, Localized Unresectable Adult Primary Liver Cancer
Completed
- Adult Primary Hepatocellular Carcinoma
- +3 more
- selumetinib
- pharmacological study
-
Tampa, Florida
- +5 more
May 12, 2014
Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer, Localized Unresectable Adult Primary Liver Cancer
Completed
- Adult Primary Hepatocellular Carcinoma
- +3 more
- cixutumumab
- +2 more
-
New York, New YorkMemorial Sloan-Kettering Cancer Center
May 7, 2014
Adult Primary Cholangiocellular Carcinoma, Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer Trial in
Terminated
- Adult Primary Cholangiocellular Carcinoma
- +13 more
- ixabepilone
- laboratory biomarker analysis
-
Chicago, IllinoisUniversity of Chicago
May 13, 2014
Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer, Localized Unresectable Adult Primary Liver Cancer
Completed
- Adult Primary Hepatocellular Carcinoma
- +3 more
- oxaliplatin
- laboratory biomarker analysis
-
Duarte, CaliforniaCity of Hope
Jun 17, 2013
Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer, Localized Unresectable Adult Primary Liver Cancer
Completed
- Adult Primary Hepatocellular Carcinoma
- +2 more
- cediranib maleate
- laboratory biomarker analysis
-
Rochester, MinnesotaNorth Central Cancer Treatment Group
Jun 4, 2013
Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer, Localized Unresectable Adult Primary Liver Cancer
Completed
- Adult Primary Hepatocellular Carcinoma
- +3 more
- bortezomib
- laboratory biomarker analysis
-
Rochester, MinnesotaMayo Clinic
Jun 3, 2013
Adult Primary Cholangiocellular Carcinoma, Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer Trial in
Completed
- Adult Primary Cholangiocellular Carcinoma
- +10 more
- erlotinib hydrochloride
- laboratory biomarker analysis
-
Rochester, MinnesotaMayo Clinic
Jun 3, 2013
Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer, Localized Unresectable Adult Primary Liver Cancer
Completed
- Adult Primary Hepatocellular Carcinoma
- +3 more
- gefitinib
- laboratory biomarker analysis
-
Boston, MassachusettsEastern Cooperative Oncology Group
Feb 26, 2013
Adenocarcinoma of the Colon, Adenocarcinoma of the Gallbladder, Adenocarcinoma of the Pancreas Trial in Philadelphia
Completed
- Adenocarcinoma of the Colon
- +41 more
- recombinant fowlpox-CEA(6D)/TRICOM vaccine
- +2 more
-
Philadelphia, PennsylvaniaFox Chase Cancer Center
Jan 24, 2013
Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer, Localized Unresectable Adult Primary Liver Cancer
Terminated
- Adult Primary Hepatocellular Carcinoma
- +2 more
- erlotinib hydrochloride
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Jan 22, 2013